174 related articles for article (PubMed ID: 29207990)
1. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.
Blanco-Prieto S; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Vázquez-Iglesias L; Botana-Rial MI; Fernández-Villar A; De Chiara L
BMC Cancer; 2017 Dec; 17(1):823. PubMed ID: 29207990
[TBL] [Abstract][Full Text] [Related]
2. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
3. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
Jumper C; Cobos E; Lox C
Respir Med; 2004 Feb; 98(2):173-7. PubMed ID: 14971882
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
An HJ; Lee YJ; Hong SA; Kim JO; Lee KY; Kim YK; Park JK; Kang JH
Pathol Res Pract; 2016 May; 212(5):357-64. PubMed ID: 26995105
[TBL] [Abstract][Full Text] [Related]
5. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer.
Ding H; Wen W; Ding Q; Zhao X
Cancer Control; 2020; 27(1):1073274820964783. PubMed ID: 33104396
[TBL] [Abstract][Full Text] [Related]
10. A multi-analyte serum test for the detection of non-small cell lung cancer.
Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
[TBL] [Abstract][Full Text] [Related]
11. Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.
Izbicka E; Streeper RT; Michalek JE; Louden CL; Diaz A; Campos DR
Cancer Genomics Proteomics; 2012 Jan; 9(1):27-35. PubMed ID: 22210046
[TBL] [Abstract][Full Text] [Related]
12. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
13. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
14. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
[TBL] [Abstract][Full Text] [Related]
15. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
Hou Y; Guo H; Guo Y; Zhang Y; Han H
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
20. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
